1. Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab
    Carlo Putzu et al, 2018, Cancer Immunology, Immunotherapy CrossRef
  2. Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
    Sara S. Fois et al, 2021, International Journal of Molecular Sciences CrossRef
  3. Long Noncoding RNAs in Non-Small Cell Lung Cancer: State of the Art
    Panagiotis Paliogiannis et al, 2020, The Chemical Biology of Long Noncoding RNAs CrossRef
  4. Genetic Instability Markers in Cancer
    Giuseppe Palmieri et al, 2020, Biomarkers for Immunotherapy of Cancer CrossRef
  5. Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
    Maria Maddalena Simile et al, 2019, Medicina CrossRef
  6. An Insight into Cholangiocarcinoma and Recent Advances in its Treatment
    Rakesh Sahu et al, 2022, Journal of Gastrointestinal Cancer CrossRef
  7. EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
    null null et al, 2019, BMC Pulmonary Medicine CrossRef
  8. Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study
    Panagiotis Paliogiannis et al, 2022, BMC Pulmonary Medicine CrossRef